CTOs on the Move

Intersect ENT

www.intersectent.com

 
Intersect ENT (Nasdaq:XENT) is dedicated to improving the quality of life for patients with ear, nose and throat conditions. The company markets the first and only drug-releasing sinus implants, PROPEL and PROPEL mini, which are clinically proven to improve surgical outcomes for patients with chronic sinusitis. The products release an advanced steroid with anti-inflammatory properties directly into the sinus lining, then dissolve, maintaining the open passages created in ethmoid sinus surgery.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Can't execute query

select mm.personal_id,pm.first_name,pm.last_name,mm.title from cto_movement_master as mm, cto_personal_master as pm where mm.personal_id=pm.personal_id and mm.company_id='544138' order by mm.personal_id desc limit 0,5

MySQL Error: MySQL server has gone away

This script cannot continue, terminating.